

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.99984079 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.93881513 |
| 3 | sarcomere organization (GO:0045214) | 8.81393536 |
| 4 | skeletal muscle contraction (GO:0003009) | 8.36953581 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.35825678 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.52772675 |
| 7 | plasma membrane repair (GO:0001778) | 7.51203353 |
| 8 | myofibril assembly (GO:0030239) | 7.50289606 |
| 9 | skeletal muscle adaptation (GO:0043501) | 6.94993144 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.68106614 |
| 11 | actin filament-based movement (GO:0030048) | 6.64285518 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.61496648 |
| 13 | striated muscle contraction (GO:0006941) | 6.58725202 |
| 14 | cardiac myofibril assembly (GO:0055003) | 6.47978684 |
| 15 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.15525648 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 5.88522747 |
| 17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.85858072 |
| 18 | carnitine shuttle (GO:0006853) | 5.82707671 |
| 19 | cardiac muscle contraction (GO:0060048) | 5.76645717 |
| 20 | creatine metabolic process (GO:0006600) | 5.73838934 |
| 21 | actomyosin structure organization (GO:0031032) | 5.73352709 |
| 22 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.67787062 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.49015997 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.48732234 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 5.35368828 |
| 26 | regulation of actin filament-based movement (GO:1903115) | 5.23502852 |
| 27 | response to inactivity (GO:0014854) | 5.09001723 |
| 28 | muscle contraction (GO:0006936) | 5.00447195 |
| 29 | cardiac muscle cell development (GO:0055013) | 4.98624091 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.98557168 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.97064517 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 4.93952236 |
| 33 | skeletal muscle fiber development (GO:0048741) | 4.92302966 |
| 34 | glycogen catabolic process (GO:0005980) | 4.85129753 |
| 35 | skeletal muscle tissue development (GO:0007519) | 4.83615789 |
| 36 | striated muscle atrophy (GO:0014891) | 4.69658070 |
| 37 | cardiac cell development (GO:0055006) | 4.67144598 |
| 38 | striated muscle adaptation (GO:0014888) | 4.65661512 |
| 39 | skeletal muscle tissue regeneration (GO:0043403) | 4.65628043 |
| 40 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.65247258 |
| 41 | response to muscle activity (GO:0014850) | 4.64600915 |
| 42 | heart process (GO:0003015) | 4.58885926 |
| 43 | heart contraction (GO:0060047) | 4.58885926 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.56161807 |
| 45 | muscle system process (GO:0003012) | 4.55564592 |
| 46 | glucan catabolic process (GO:0009251) | 4.52078240 |
| 47 | regulation of coenzyme metabolic process (GO:0051196) | 4.46246561 |
| 48 | regulation of cofactor metabolic process (GO:0051193) | 4.46246561 |
| 49 | fructose metabolic process (GO:0006000) | 4.42245176 |
| 50 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.41393338 |
| 51 | carnitine transmembrane transport (GO:1902603) | 4.31741566 |
| 52 | cardiac muscle hypertrophy (GO:0003300) | 4.31113524 |
| 53 | striated muscle hypertrophy (GO:0014897) | 4.30739079 |
| 54 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.30629998 |
| 55 | muscle fiber development (GO:0048747) | 4.27357967 |
| 56 | muscle organ morphogenesis (GO:0048644) | 4.26563811 |
| 57 | myotube cell development (GO:0014904) | 4.26540937 |
| 58 | cellular polysaccharide catabolic process (GO:0044247) | 4.23537221 |
| 59 | muscle tissue morphogenesis (GO:0060415) | 4.16047137 |
| 60 | adult heart development (GO:0007512) | 4.14591183 |
| 61 | muscle atrophy (GO:0014889) | 4.10028087 |
| 62 | regulation of sarcomere organization (GO:0060297) | 4.09391447 |
| 63 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.08968055 |
| 64 | cytidine deamination (GO:0009972) | 4.08234342 |
| 65 | cytidine metabolic process (GO:0046087) | 4.08234342 |
| 66 | cytidine catabolic process (GO:0006216) | 4.08234342 |
| 67 | glycogen biosynthetic process (GO:0005978) | 4.06795419 |
| 68 | glucan biosynthetic process (GO:0009250) | 4.06795419 |
| 69 | gluconeogenesis (GO:0006094) | 4.03708092 |
| 70 | response to activity (GO:0014823) | 4.02710825 |
| 71 | muscle cell fate commitment (GO:0042693) | 4.01012363 |
| 72 | striated muscle cell development (GO:0055002) | 4.00910478 |
| 73 | polysaccharide catabolic process (GO:0000272) | 4.00750709 |
| 74 | positive regulation of myotube differentiation (GO:0010831) | 3.94855853 |
| 75 | regulation of membrane repolarization (GO:0060306) | 3.94117487 |
| 76 | muscle structure development (GO:0061061) | 3.93824339 |
| 77 | amino-acid betaine transport (GO:0015838) | 3.90905527 |
| 78 | carnitine transport (GO:0015879) | 3.90905527 |
| 79 | muscle adaptation (GO:0043500) | 3.89331162 |
| 80 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.87710699 |
| 81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.87168382 |
| 82 | muscle hypertrophy (GO:0014896) | 3.80666570 |
| 83 | negative regulation of muscle hypertrophy (GO:0014741) | 3.73822649 |
| 84 | neuronal action potential propagation (GO:0019227) | 3.69880272 |
| 85 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.69804737 |
| 86 | regulation of sulfur metabolic process (GO:0042762) | 3.66026507 |
| 87 | ubiquinone biosynthetic process (GO:0006744) | 3.63709154 |
| 88 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.63000652 |
| 89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.63000652 |
| 90 | myoblast fusion (GO:0007520) | 3.62153560 |
| 91 | IMP metabolic process (GO:0046040) | 3.61927361 |
| 92 | hexose biosynthetic process (GO:0019319) | 3.60607810 |
| 93 | heart trabecula formation (GO:0060347) | 3.58200551 |
| 94 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.57439015 |
| 95 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.57439015 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57259227 |
| 97 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57193112 |
| 98 | regulation of sequestering of triglyceride (GO:0010889) | 3.55412692 |
| 99 | negative regulation of muscle contraction (GO:0045932) | 3.53369384 |
| 100 | NADH metabolic process (GO:0006734) | 3.51038945 |
| 101 | purine nucleotide salvage (GO:0032261) | 3.47867165 |
| 102 | muscle cell cellular homeostasis (GO:0046716) | 3.47784422 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.45452326 |
| 104 | glycogen metabolic process (GO:0005977) | 3.45102922 |
| 105 | cellular carbohydrate catabolic process (GO:0044275) | 3.45089905 |
| 106 | negative regulation of protein localization to cell surface (GO:2000009) | 3.45026824 |
| 107 | muscle cell development (GO:0055001) | 3.42045714 |
| 108 | positive regulation of cation channel activity (GO:2001259) | 3.41689921 |
| 109 | oxidative phosphorylation (GO:0006119) | 3.39710772 |
| 110 | myotube differentiation (GO:0014902) | 3.38391863 |
| 111 | cellular glucan metabolic process (GO:0006073) | 3.37569906 |
| 112 | glucan metabolic process (GO:0044042) | 3.37569906 |
| 113 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.35614177 |
| 114 | cardiac muscle adaptation (GO:0014887) | 3.34825068 |
| 115 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.34825068 |
| 116 | muscle hypertrophy in response to stress (GO:0003299) | 3.34825068 |
| 117 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.32656226 |
| 118 | neuromuscular synaptic transmission (GO:0007274) | 3.31347552 |
| 119 | muscle organ development (GO:0007517) | 3.30760462 |
| 120 | respiratory electron transport chain (GO:0022904) | 3.29809582 |
| 121 | succinate metabolic process (GO:0006105) | 3.27602057 |
| 122 | regulation of myoblast differentiation (GO:0045661) | 3.27262567 |
| 123 | striated muscle tissue development (GO:0014706) | 3.27077792 |
| 124 | ubiquinone metabolic process (GO:0006743) | 3.22395004 |
| 125 | relaxation of muscle (GO:0090075) | 3.20640745 |
| 126 | actin-myosin filament sliding (GO:0033275) | 10.8831926 |
| 127 | muscle filament sliding (GO:0030049) | 10.8831926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.56390135 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.86528117 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.90850625 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.80761095 |
| 5 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.67738333 |
| 6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.67738333 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.62723199 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.52460567 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71241120 |
| 10 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.68628746 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.68003487 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.43102395 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38058278 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.33662957 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.28032730 |
| 16 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.17460287 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.15899586 |
| 18 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.14496008 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08295807 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99750478 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.88194822 |
| 22 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.76600792 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72532986 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.70421364 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63502289 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61490183 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.50212930 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48447809 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47166434 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.46641887 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46449658 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41427690 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40211104 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39965182 |
| 35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.39337903 |
| 36 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.38178392 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32987111 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.30537427 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29810272 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28760421 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28721920 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27369693 |
| 43 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25830166 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24547070 |
| 45 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.23495885 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.22078470 |
| 47 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.22048189 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21323938 |
| 49 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17950441 |
| 50 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16660030 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15940259 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15726126 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13282406 |
| 54 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.13100948 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12040491 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10400989 |
| 57 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09059919 |
| 58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08849769 |
| 59 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.08222790 |
| 60 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07644815 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07078185 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06292100 |
| 63 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05798971 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05714038 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04387712 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.04050258 |
| 67 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04037471 |
| 68 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.03603744 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02253773 |
| 70 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00444646 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00371323 |
| 72 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97659998 |
| 73 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96384911 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96025441 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95341778 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95238256 |
| 77 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94948110 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94186809 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93638757 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93452624 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93336300 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92447100 |
| 83 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92124999 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91916481 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91711221 |
| 86 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91454939 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90754853 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90417491 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89437357 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89381035 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89099722 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88956472 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85671888 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84881997 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84730716 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84207415 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83933078 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83434117 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83210242 |
| 100 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82758278 |
| 101 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.82665227 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82526161 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81678421 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81673146 |
| 105 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81530907 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81116417 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80667718 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80448923 |
| 109 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.80350600 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80034743 |
| 111 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79118128 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78259230 |
| 113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78174960 |
| 114 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77618812 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77249961 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77170462 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76997461 |
| 118 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76918825 |
| 119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76802491 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76411607 |
| 121 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.76389002 |
| 122 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76225589 |
| 123 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.75730808 |
| 124 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75249711 |
| 125 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.74885722 |
| 126 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74395266 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73884869 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73868147 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73864138 |
| 130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73464389 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73211533 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.73115657 |
| 133 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.73115657 |
| 134 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72893840 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72657881 |
| 136 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71436957 |
| 137 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.71283076 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71067370 |
| 139 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.70527176 |
| 140 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70070480 |
| 141 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68691938 |
| 142 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.68316180 |
| 143 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.67770424 |
| 144 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66805436 |
| 145 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.66785988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.70784722 |
| 2 | MP0000751_myopathy | 5.85110573 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 5.70115769 |
| 4 | MP0000749_muscle_degeneration | 5.56802517 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 5.43237390 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.36294532 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.86331093 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.65083003 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.48365074 |
| 10 | MP0000747_muscle_weakness | 3.44021431 |
| 11 | MP0004215_abnormal_myocardial_fiber | 3.29957045 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.24499560 |
| 13 | MP0000759_abnormal_skeletal_muscle | 3.13106252 |
| 14 | MP0005330_cardiomyopathy | 3.10511604 |
| 15 | MP0002269_muscular_atrophy | 3.10062773 |
| 16 | MP0005620_abnormal_muscle_contractility | 3.09870038 |
| 17 | MP0004130_abnormal_muscle_cell | 3.03992783 |
| 18 | MP0005369_muscle_phenotype | 3.03783648 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.34837683 |
| 20 | MP0004233_abnormal_muscle_weight | 2.16874103 |
| 21 | MP0004484_altered_response_of | 2.02484735 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.02150071 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.96803732 |
| 24 | MP0003137_abnormal_impulse_conducting | 1.91952881 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.88976175 |
| 26 | MP0005385_cardiovascular_system_phenoty | 1.86130926 |
| 27 | MP0001544_abnormal_cardiovascular_syste | 1.86130926 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.82087384 |
| 29 | MP0000733_abnormal_muscle_development | 1.68032347 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.66046904 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.65800444 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.49746710 |
| 33 | MP0006138_congestive_heart_failure | 1.44604269 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.39724778 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.34823053 |
| 36 | MP0003828_pulmonary_edema | 1.32958917 |
| 37 | MP0004085_abnormal_heartbeat | 1.23319730 |
| 38 | MP0004510_myositis | 1.20089493 |
| 39 | MP0002127_abnormal_cardiovascular_syste | 1.13643155 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.11950416 |
| 41 | MP0005670_abnormal_white_adipose | 1.11517396 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.08972332 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.07800998 |
| 44 | MP0001661_extended_life_span | 1.06744474 |
| 45 | MP0002971_abnormal_brown_adipose | 1.02441585 |
| 46 | MP0000343_altered_response_to | 1.00153237 |
| 47 | MP0005266_abnormal_metabolism | 0.99401047 |
| 48 | MP0002234_abnormal_pharynx_morphology | 0.91878715 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 0.91018809 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 0.89999716 |
| 51 | MP0000266_abnormal_heart_morphology | 0.87611789 |
| 52 | MP0004147_increased_porphyrin_level | 0.83645363 |
| 53 | MP0000003_abnormal_adipose_tissue | 0.71807654 |
| 54 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69399018 |
| 55 | MP0004043_abnormal_pH_regulation | 0.64465093 |
| 56 | MP0003879_abnormal_hair_cell | 0.63482505 |
| 57 | MP0005165_increased_susceptibility_to | 0.61080330 |
| 58 | MP0000230_abnormal_systemic_arterial | 0.58207895 |
| 59 | MP0002638_abnormal_pupillary_reflex | 0.56366081 |
| 60 | MP0003279_aneurysm | 0.55478736 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.55356093 |
| 62 | MP0004142_abnormal_muscle_tone | 0.53846040 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.53540809 |
| 64 | MP0002128_abnormal_blood_circulation | 0.52632786 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.50414502 |
| 66 | MP0005334_abnormal_fat_pad | 0.46398888 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.45190307 |
| 68 | MP0004270_analgesia | 0.44918425 |
| 69 | MP0005275_abnormal_skin_tensile | 0.44099963 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.41416474 |
| 71 | MP0001346_abnormal_lacrimal_gland | 0.40014782 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 0.39986704 |
| 73 | MP0005423_abnormal_somatic_nervous | 0.39547182 |
| 74 | MP0010030_abnormal_orbit_morphology | 0.38855632 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 0.37108341 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.37019887 |
| 77 | MP0005451_abnormal_body_composition | 0.36322067 |
| 78 | MP0004134_abnormal_chest_morphology | 0.36243040 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 0.35936026 |
| 80 | MP0005332_abnormal_amino_acid | 0.34215781 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.33953598 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.33215927 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.33055740 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.32407943 |
| 85 | MP0005452_abnormal_adipose_tissue | 0.31655092 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30601124 |
| 87 | MP0000762_abnormal_tongue_morphology | 0.29533960 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.29333171 |
| 89 | MP0005083_abnormal_biliary_tract | 0.29187506 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 0.28608895 |
| 91 | MP0005535_abnormal_body_temperature | 0.28579624 |
| 92 | MP0003045_fibrosis | 0.28444177 |
| 93 | MP0001853_heart_inflammation | 0.28366580 |
| 94 | MP0005503_abnormal_tendon_morphology | 0.28219221 |
| 95 | MP0005166_decreased_susceptibility_to | 0.28002992 |
| 96 | MP0009115_abnormal_fat_cell | 0.27254754 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.26122053 |
| 98 | MP0008569_lethality_at_weaning | 0.25693516 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.25603039 |
| 100 | MP0002822_catalepsy | 0.24731329 |
| 101 | MP0002066_abnormal_motor_capabilities/c | 0.24651670 |
| 102 | MP0002925_abnormal_cardiovascular_devel | 0.24625553 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.24515483 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.23408238 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.23266654 |
| 106 | MP0001943_abnormal_respiration | 0.22284890 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.21399924 |
| 108 | MP0005187_abnormal_penis_morphology | 0.21146937 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.21084522 |
| 110 | MP0004924_abnormal_behavior | 0.21036293 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.21036293 |
| 112 | MP0001529_abnormal_vocalization | 0.20995972 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.19416586 |
| 114 | MP0001614_abnormal_blood_vessel | 0.19225618 |
| 115 | MP0002067_abnormal_sensory_capabilities | 0.19224111 |
| 116 | MP0003959_abnormal_lean_body | 0.18658358 |
| 117 | MP0003195_calcinosis | 0.18547705 |
| 118 | MP0002118_abnormal_lipid_homeostasis | 0.18330751 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.16936606 |
| 120 | MP0001784_abnormal_fluid_regulation | 0.16469467 |
| 121 | MP0009672_abnormal_birth_weight | 0.15697203 |
| 122 | MP0002970_abnormal_white_adipose | 0.14549887 |
| 123 | MP0002249_abnormal_larynx_morphology | 0.12737548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 8.25022860 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.87737004 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.74287488 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.56220611 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.27198774 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 6.98938120 |
| 7 | Nemaline bodies (HP:0003798) | 6.97523919 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 6.03270295 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.96751519 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.47783350 |
| 11 | Myoglobinuria (HP:0002913) | 5.45413485 |
| 12 | Sudden death (HP:0001699) | 5.21713754 |
| 13 | Distal arthrogryposis (HP:0005684) | 5.21581631 |
| 14 | Difficulty running (HP:0009046) | 5.16166786 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 5.10420054 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.93945151 |
| 17 | Myopathic facies (HP:0002058) | 4.92330698 |
| 18 | Round ear (HP:0100830) | 4.63264488 |
| 19 | Increased connective tissue (HP:0009025) | 4.60374317 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.58760079 |
| 21 | Subaortic stenosis (HP:0001682) | 4.58760079 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.48176096 |
| 23 | Ventricular tachycardia (HP:0004756) | 4.26938729 |
| 24 | Myotonia (HP:0002486) | 4.23340288 |
| 25 | Ulnar deviation of the wrist (HP:0003049) | 4.22742460 |
| 26 | Muscle stiffness (HP:0003552) | 4.20317850 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.62166471 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.57222748 |
| 29 | Difficulty climbing stairs (HP:0003551) | 3.53349399 |
| 30 | Calcaneovalgus deformity (HP:0001848) | 3.53180308 |
| 31 | Neck muscle weakness (HP:0000467) | 3.41335062 |
| 32 | Lipoatrophy (HP:0100578) | 3.38665799 |
| 33 | Absent phalangeal crease (HP:0006109) | 3.36372463 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 3.31853181 |
| 35 | Deformed tarsal bones (HP:0008119) | 3.30934725 |
| 36 | Areflexia of lower limbs (HP:0002522) | 3.29708769 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.23976413 |
| 38 | Atrial fibrillation (HP:0005110) | 3.20928174 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 3.06609675 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 3.01061389 |
| 41 | Primary atrial arrhythmia (HP:0001692) | 2.97402116 |
| 42 | Bundle branch block (HP:0011710) | 2.89437852 |
| 43 | Supraventricular tachycardia (HP:0004755) | 2.86751799 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.82864395 |
| 45 | Supraventricular arrhythmia (HP:0005115) | 2.80134717 |
| 46 | Malignant hyperthermia (HP:0002047) | 2.79361678 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 2.76728241 |
| 48 | Frequent falls (HP:0002359) | 2.71013720 |
| 49 | Palpitations (HP:0001962) | 2.63476491 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.53283460 |
| 51 | EMG: neuropathic changes (HP:0003445) | 2.48739102 |
| 52 | Limb-girdle muscle atrophy (HP:0003797) | 2.47305258 |
| 53 | Abnormality of the neuromuscular junction (HP:0003398) | 2.46489760 |
| 54 | Fatigable weakness (HP:0003473) | 2.46489760 |
| 55 | Muscular dystrophy (HP:0003560) | 2.45785744 |
| 56 | Prolonged QT interval (HP:0001657) | 2.44952226 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.40347502 |
| 58 | Generalized muscle weakness (HP:0003324) | 2.37697115 |
| 59 | Heart block (HP:0012722) | 2.37421910 |
| 60 | Gowers sign (HP:0003391) | 2.35910392 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34125279 |
| 62 | Ventricular arrhythmia (HP:0004308) | 2.33115657 |
| 63 | Facial diplegia (HP:0001349) | 2.32774885 |
| 64 | Hyperkalemia (HP:0002153) | 2.31738801 |
| 65 | Syncope (HP:0001279) | 2.30831775 |
| 66 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.26986005 |
| 67 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.26986005 |
| 68 | Bulbar palsy (HP:0001283) | 2.26159623 |
| 69 | Abnormal atrioventricular conduction (HP:0005150) | 2.25242514 |
| 70 | Proximal amyotrophy (HP:0007126) | 2.24250232 |
| 71 | Pelvic girdle muscle weakness (HP:0003749) | 2.22629931 |
| 72 | Shoulder girdle muscle weakness (HP:0003547) | 2.22462025 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.18368758 |
| 74 | Weak cry (HP:0001612) | 2.17377186 |
| 75 | Limb-girdle muscle weakness (HP:0003325) | 2.15126735 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.09709826 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.08863327 |
| 78 | Abnormality of the ischium (HP:0003174) | 2.08155915 |
| 79 | Scapular winging (HP:0003691) | 2.08120410 |
| 80 | Waddling gait (HP:0002515) | 2.07752297 |
| 81 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00909751 |
| 82 | Abnormality of the calcaneus (HP:0008364) | 2.00745989 |
| 83 | Atrioventricular block (HP:0001678) | 1.99659472 |
| 84 | Lower limb amyotrophy (HP:0007210) | 1.98435337 |
| 85 | Spinal rigidity (HP:0003306) | 1.96756378 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95592232 |
| 87 | Left ventricular hypertrophy (HP:0001712) | 1.93254084 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 1.91366933 |
| 89 | Testicular atrophy (HP:0000029) | 1.90628021 |
| 90 | Exercise intolerance (HP:0003546) | 1.90525177 |
| 91 | Slender build (HP:0001533) | 1.89198066 |
| 92 | Hepatic necrosis (HP:0002605) | 1.85891787 |
| 93 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82516249 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 1.82378086 |
| 95 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.82199377 |
| 96 | Increased muscle lipid content (HP:0009058) | 1.79680969 |
| 97 | Paralysis (HP:0003470) | 1.78558032 |
| 98 | Long clavicles (HP:0000890) | 1.77286426 |
| 99 | Abnormal EKG (HP:0003115) | 1.76874757 |
| 100 | Ventricular fibrillation (HP:0001663) | 1.76728065 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 1.74290412 |
| 102 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73211223 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 1.72994001 |
| 104 | Ketoacidosis (HP:0001993) | 1.72420808 |
| 105 | Hip contracture (HP:0003273) | 1.71562750 |
| 106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68658233 |
| 107 | Hyperalaninemia (HP:0003348) | 1.68658233 |
| 108 | Nonprogressive disorder (HP:0003680) | 1.66739203 |
| 109 | Popliteal pterygium (HP:0009756) | 1.60336327 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.55156845 |
| 111 | Metatarsus adductus (HP:0001840) | 1.53472373 |
| 112 | Ulnar deviation of finger (HP:0009465) | 1.50955636 |
| 113 | Muscle fiber atrophy (HP:0100295) | 1.44702202 |
| 114 | Limited hip movement (HP:0008800) | 1.38453725 |
| 115 | Oligomenorrhea (HP:0000876) | 1.36735645 |
| 116 | Steppage gait (HP:0003376) | 1.28606407 |
| 117 | Congenital hip dislocation (HP:0001374) | 1.28565911 |
| 118 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.28096829 |
| 119 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.24297141 |
| 120 | Stridor (HP:0010307) | 1.19110502 |
| 121 | Easy fatigability (HP:0003388) | 1.18954343 |
| 122 | Neonatal hypotonia (HP:0001319) | 1.18944968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.53358957 |
| 2 | TTN | 6.74291388 |
| 3 | PHKG2 | 5.30510354 |
| 4 | PHKG1 | 5.30510354 |
| 5 | NME1 | 2.81022863 |
| 6 | PDK3 | 2.72279173 |
| 7 | PDK4 | 2.72279173 |
| 8 | MUSK | 2.48541599 |
| 9 | PINK1 | 2.48095772 |
| 10 | DMPK | 2.47789290 |
| 11 | PIK3CG | 2.38813096 |
| 12 | MAP2K3 | 2.27097248 |
| 13 | NEK1 | 2.16343756 |
| 14 | BCKDK | 2.14903223 |
| 15 | PIK3CA | 2.11626762 |
| 16 | TRIB3 | 2.03290968 |
| 17 | PDK2 | 1.78340147 |
| 18 | MAP3K7 | 1.74338113 |
| 19 | LMTK2 | 1.61778473 |
| 20 | PKN2 | 1.52338788 |
| 21 | MYLK | 1.50627742 |
| 22 | MAPK12 | 1.49347847 |
| 23 | TIE1 | 1.24575092 |
| 24 | STK24 | 1.19761031 |
| 25 | MARK1 | 1.08874189 |
| 26 | ZAK | 1.08389030 |
| 27 | MAP2K6 | 0.91583686 |
| 28 | MAP3K3 | 0.90408420 |
| 29 | PRKAA1 | 0.90406590 |
| 30 | PRKAA2 | 0.89397628 |
| 31 | TRPM7 | 0.86413995 |
| 32 | MOS | 0.86310053 |
| 33 | MAP2K4 | 0.85676587 |
| 34 | MAPKAPK3 | 0.84808329 |
| 35 | NEK9 | 0.83154612 |
| 36 | CCNB1 | 0.83131872 |
| 37 | DYRK1B | 0.77370284 |
| 38 | PRKD1 | 0.71898119 |
| 39 | ILK | 0.71633570 |
| 40 | CAMK2D | 0.70265031 |
| 41 | GRK7 | 0.69914216 |
| 42 | EPHB1 | 0.68741737 |
| 43 | MAP3K13 | 0.65274908 |
| 44 | PKN1 | 0.64445593 |
| 45 | MAP3K5 | 0.59775925 |
| 46 | ROCK1 | 0.59398647 |
| 47 | AKT2 | 0.59359481 |
| 48 | INSRR | 0.51859929 |
| 49 | CAMK2G | 0.50754008 |
| 50 | RIPK1 | 0.47748297 |
| 51 | MAPK11 | 0.43015795 |
| 52 | TAOK2 | 0.42904534 |
| 53 | PAK3 | 0.42710526 |
| 54 | CAMK2B | 0.40720363 |
| 55 | PRKACB | 0.40333497 |
| 56 | TGFBR2 | 0.40303699 |
| 57 | FLT3 | 0.40277624 |
| 58 | ERBB3 | 0.37931130 |
| 59 | KSR2 | 0.36863129 |
| 60 | SIK1 | 0.34625239 |
| 61 | STK38L | 0.34537509 |
| 62 | SGK2 | 0.34203208 |
| 63 | PTK6 | 0.33406262 |
| 64 | MAP3K11 | 0.33064852 |
| 65 | MAPK13 | 0.32852306 |
| 66 | TBK1 | 0.31718192 |
| 67 | TAOK1 | 0.30442050 |
| 68 | PRKACA | 0.29765945 |
| 69 | ROCK2 | 0.29662622 |
| 70 | RPS6KB1 | 0.29355337 |
| 71 | SGK1 | 0.27329434 |
| 72 | PRKG1 | 0.26520291 |
| 73 | MAPK7 | 0.26229629 |
| 74 | ICK | 0.25081146 |
| 75 | CAMK4 | 0.24714442 |
| 76 | RPS6KC1 | 0.24309475 |
| 77 | RPS6KL1 | 0.24309475 |
| 78 | CAMK2A | 0.22982101 |
| 79 | PDPK1 | 0.22911891 |
| 80 | KDR | 0.22496896 |
| 81 | MARK2 | 0.21567428 |
| 82 | STK4 | 0.21523319 |
| 83 | MAPK10 | 0.21515704 |
| 84 | RPS6KB2 | 0.21386290 |
| 85 | CDK19 | 0.21358965 |
| 86 | DAPK2 | 0.20642471 |
| 87 | ARAF | 0.20634564 |
| 88 | MAP3K1 | 0.20095392 |
| 89 | RPS6KA6 | 0.19953471 |
| 90 | SGK3 | 0.19510171 |
| 91 | WNK1 | 0.18846523 |
| 92 | RPS6KA3 | 0.18755420 |
| 93 | PDK1 | 0.18328227 |
| 94 | PRKACG | 0.18269821 |
| 95 | PDGFRA | 0.17012531 |
| 96 | LATS2 | 0.16949107 |
| 97 | STK38 | 0.16696723 |
| 98 | MAPK4 | 0.16249902 |
| 99 | CDC42BPA | 0.16216027 |
| 100 | MAP3K9 | 0.16167399 |
| 101 | PTK2B | 0.16008963 |
| 102 | RPS6KA1 | 0.15885311 |
| 103 | SGK494 | 0.15763593 |
| 104 | SGK223 | 0.15763593 |
| 105 | PRPF4B | 0.14410859 |
| 106 | NME2 | 0.13215560 |
| 107 | TYK2 | 0.12892705 |
| 108 | NLK | 0.12510711 |
| 109 | DAPK3 | 0.11624477 |
| 110 | CAMK1 | 0.10870309 |
| 111 | PRKCH | 0.10475880 |
| 112 | STK11 | 0.10145672 |
| 113 | RPS6KA2 | 0.09746137 |
| 114 | WNK4 | 0.09008699 |
| 115 | TNK2 | 0.08807412 |
| 116 | MARK3 | 0.08659928 |
| 117 | JAK1 | 0.08592329 |
| 118 | MAP2K1 | 0.08566141 |
| 119 | ZAP70 | 0.07974769 |
| 120 | RAF1 | 0.07709641 |
| 121 | MTOR | 0.05892704 |
| 122 | LIMK1 | 0.05691931 |
| 123 | MAP3K6 | 0.04375886 |
| 124 | BRAF | 0.04344382 |
| 125 | JAK2 | 0.04233291 |
| 126 | GSK3B | 0.04027100 |
| 127 | EEF2K | 0.03582734 |
| 128 | MAPK9 | 0.03189411 |
| 129 | PRKCE | 0.03177051 |
| 130 | MAPK3 | 0.03101241 |
| 131 | MAPK8 | 0.01948561 |
| 132 | MAPKAPK2 | 0.01873051 |
| 133 | CSNK1D | 0.01555316 |
| 134 | MAP3K10 | 0.00821477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.47513349 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.33167906 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.27011392 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.98003062 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.94119187 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.28815308 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.03633024 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.83582310 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71665078 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69014232 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.38135430 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35620094 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.26359697 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.15239882 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.00582142 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98956540 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85215892 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71812979 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70874864 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62367407 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.61946098 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.59643195 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.59580872 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.54427811 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53480025 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.40923825 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36616976 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31944205 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20890867 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16911155 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15370941 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14736065 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13416240 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11383585 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07730782 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.02697250 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01147122 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96615777 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88970930 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86969632 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.85451749 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 0.85049036 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84706768 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82853018 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81912322 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81118827 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73556549 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73125787 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68117872 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62935841 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62393866 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58126902 |
| 53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53389594 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51264723 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49551043 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49515077 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49493309 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47942741 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46189522 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45327496 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.44668805 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44000130 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.43099940 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42686298 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.39648946 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38774407 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38440379 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37937437 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.37602107 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.36238964 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.35201239 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34778988 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34152739 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.33669879 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33382519 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.31527690 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.31507185 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30775063 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29741446 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27471252 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27288394 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26873870 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26651556 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25880288 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23537345 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23383680 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22589077 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20564726 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18733929 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18180359 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18115073 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.16236233 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15994465 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.11876025 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.10833392 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10003036 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09668425 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09501422 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08616933 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08145062 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.07896884 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.07506608 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07087402 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06272660 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04927445 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.04851500 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.04347032 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.03715500 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.02755183 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.02512254 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.01488739 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00517602 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.00332769 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.00193807 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0524675 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0442212 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0424016 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | -0.0353142 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | -0.0316735 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0142899 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | -0.0048274 |

